Pressmeddelanden från Vistin Pharma

Bevaka pressreleaser

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

Vistin Pharma ASA: Notice of Annual General Meeting 20 May 2026 24 apr 16:40

2025 Annual Report Vistin Pharma ASA 24 apr 07:40

Vistin Pharma ASA: First quarter 2026 financial results 17 apr 10:30

Vistin Pharma ASA: Invitation to Q1 2026 conference call 20 feb 19:30

Vistin Pharma ASA: Mandatory notification of trade 12 feb 11:55

Vistin Pharma ASA (VISTN): Key information relating to the proposed cash dividend 12 feb 07:50

Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results 05 feb 10:00

Vistin Pharma ASA (VISTN): Invitation to Q4 2025 conference call 31 okt 2025 07:40

Vistin Pharma ASA: Third quarter and YTD 2025 financial results 24 okt 2025 10:00

Vistin Pharma ASA: Invitation to Q3 2025 conference call 15 aug 2025 08:00

Vistin Pharma ASA: Second quarter and YTD 2025 financial results 08 aug 2025 10:00

Vistin Pharma ASA: Invitation to Q2 2025 conference call 04 jun 2025 08:00

Ex dividend NOK 1.25 today 22 maj 2025 14:59

Vistin Pharma ASA: Minutes from the annual general meeting 2025 22 maj 2025 11:56

Disclosure of voting rights at AGM in Vistin Pharma ASA 07 maj 2025 15:30

Vistin Pharma ASA (VISTN): Update from the Election Committee 06 maj 2025 15:03

Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of large shareholding 29 apr 2025 11:30

Vistin Pharma ASA: Notice of Annual General Meeting 22 May 2025 25 apr 2025 16:40

2024 Annual Report Vistin Pharma ASA 25 apr 2025 07:35

Vistin Pharma ASA: First quarter 2025 financial results 15 apr 2025 13:00

Vistin Pharma ASA: Invitation to Q1 2025 conference call 13 feb 2025 12:00

Vistin Pharma ASA: Key information relating to the proposed cash dividend 13 feb 2025 07:35

Vistin Pharma ASA: Fourth quarter and preliminary 2024 financial results 06 feb 2025 11:00

Vistin Pharma ASA: Invitation to Q4 2024 conference call 06 nov 2024 07:45

Ex dividend NOK 0.50 today 31 okt 2024 07:40

Vistin Pharma ASA: Third quarter and YTD 2024 financial results 24 okt 2024 10:00

Vistin Pharma ASA: Invitation to Q3 2024 conference call 21 okt 2024 17:00

Responsibility statement for first half year of 2024 26 sep 2024 17:27

Vistin Pharma ASA: Mandatory notification of trade 13 sep 2024 17:10

Disclosure of large shareholding and mandatory notification of trade in Vistin Pharma ASA 23 aug 2024 16:06

Vistin Pharma ASA: Mandatory notification of trade 23 aug 2024 07:40

Vistin Pharma ASA: Second quarter and first half 2024 financial results 16 aug 2024 10:00

Vistin Pharma ASA: Invitation to Q2 2024 conference call 05 jun 2024 08:05

Ex dividend NOK 0.50 today 23 maj 2024 14:50

Vistin Pharma ASA: Minutes from the annual general meeting 2024 23 maj 2024 12:56

Disclosure of voting rights at AGM in Vistin Pharma ASA 30 apr 2024 08:58

Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024 24 apr 2024 23:10

Vistin Pharma ASA: Annual Report 2023 24 apr 2024 07:44

Vistin Pharma ASA: First quarter 2024 financial results 22 mar 2024 21:59

Vistin Pharma ASA: Mandatory notification of trade 04 mar 2024 08:15

Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary)16 feb 2024 10:30

Vistin Pharma ASA: Key information relating to the proposed cash dividend 16 feb 2024 07:45

Vistin Pharma ASA: Fourth quarter and preliminary 2023 financial results 09 feb 2024 10:00

Vistin Pharma ASA: Invitation to Q4 2023 conference call 23 jan 2024 08:00

Ex dividend NOK 0.75 today 11 jan 2024 11:40

Key information relating to the cash dividend to be paid by Vistin Pharma ASA 11 jan 2024 11:35

Vistin Pharma ASA: Dividend of NOK 0.75 per share 25 okt 2023 07:45

Vistin Pharma ASA: New CEO appointed 25 okt 2023 07:45

Vistin Pharma ASA: Third quarter 2023 financial results 18 okt 2023 13:00

Vistin Pharma ASA: Invitation to Q3 2023 conference call 18 sep 2023 18:40

Vistin Pharma ASA: Mandatory notification of trade 26 aug 2023 09:40

Mandatory notification of trade in Vistin Pharma ASA 23 aug 2023 07:35

Vistin Pharma ASA: Second quarter and first half 2023 financial results 16 aug 2023 12:00

Vistin Pharma ASA: Invitation to Q2 2023 conference call 04 jul 2023 08:30

Management in Vistin Pharma ASA purchases shares 04 jul 2023 08:00

Vistin Pharma ASA: Results of offer to buy back shares 30 jun 2023 07:30

Vistin Pharma ASA: Offer to buy back shares 14 jun 2023 15:15

Vistin Pharma ASA (OSE: VISTIN): Presentation from today's Capital Markets Day 31 maj 2023 12:05

Vistin Pharma ASA: Mandatory notification of trade 30 maj 2023 21:00

Vistin Pharma ASA: Mandatory notification of trade 22 maj 2023 14:52

Vistin Pharma ASA: Minutes from the Annual General Meeting 2023 12 maj 2023 17:30

Disclosure of voting rights at AGM in Vistin Pharma ASA 11 maj 2023 11:00

Vistin Pharma ASA (OSE: VISTIN): Invitation to Capital Markets Day on 14th of June at the metformin manufacturing plant in Kragerø 28 apr 2023 12:30

Notice of Annual General Meeting in Vistin Pharma ASA 27 apr 2023 17:35

Vistin Pharma ASA: Annual Report for 2022 27 apr 2023 07:50

Vistin Pharma ASA: First quarter 2023 financial results 20 apr 2023 11:00

Vistin Pharma ASA: Invitation to Q1 2023 conference call 17 feb 2023 08:00

Vistin Pharma ASA: Fourth quarter and preliminary 2022 financial results 10 feb 2023 10:00

Vistin Pharma ASA: Invitation to Q4 2022 conference call 09 dec 2022 12:10

Vistin Pharma enters into a long-term renewable energy supply agreement with Statkraft 26 okt 2022 07:45

Vistin Pharma ASA: Third quarter and YTD 2022 financial results 18 okt 2022 14:00

Vistin Pharma ASA: Invitation to Q3 2022 conference call 19 aug 2022 07:50

Vistin Pharma ASA: Second quarter and first half 2022 financial results 11 aug 2022 13:00

Vistin Pharma ASA: Invitation to Q2 2022 conference call 19 maj 2022 11:50

Vistin Pharma ASA: Minutes from the annual general meeting 2022 28 apr 2022 13:00

Vistin Pharma ASA: Notice of Annual General Meeting 27 apr 2022 13:00

Vistin Pharma ASA: Annual Report for 2021 27 apr 2022 07:45

Vistin Pharma ASA: First quarter 2022 financial results 20 apr 2022 13:00

Vistin Pharma ASA: Invitation to Q1 2022 conference call 17 feb 2022 07:40

Vistin Pharma ASA: Fourth quarter 2021 financial results 16 feb 2022 15:45

New interim CEO 08 feb 2022 14:00

Vistin Pharma ASA: Invitation to Q4 2021 conference call 29 okt 2021 14:39

Vistin Pharma ASA: Mandatory notification of trade 28 okt 2021 07:45

Vistin Pharma ASA: Third quarter 2021 financial results 21 okt 2021 12:00

Vistin Pharma ASA: Invitation to Q3 2021 conference call 14 sep 2021 08:34

Mandatory notification of trade in Vistin Pharma ASA 19 aug 2021 07:45

Vistin Pharma ASA: Second quarter and first half 2021 financial results 12 aug 2021 13:00

Vistin Pharma ASA: Invitation to Q2 2021 conference call 21 maj 2021 08:00

Vistin Pharma ASA: Ex dividend NOK 0.5 today 20 maj 2021 14:55

Vistin Pharma ASA: Minutes from the annual general meeting 2021 19 maj 2021 08:30

Vistin Pharma ASA: Mandatory notification of trade 04 maj 2021 08:50

CORRECTION: Vistin Pharma ASA : Key information relating to the cash dividend 30 apr 2021 11:22

Vistin Pharma ASA : Key information relating to the cash dividend to be paid by Vistin Pharma ASA 28 apr 2021 12:30

Vistin Pharma ASA : Call for annual general meeting 23 apr 2021 12:00

Vistin Pharma ASA: Annual Report for 2020 23 apr 2021 07:45

Vistin Pharma ASA: First quarter 2021 financial results 16 apr 2021 15:00

Vistin Pharma ASA: Invitation to Q1 2021 conference call 16 mar 2021 08:30

Vistin Pharma ASA: Mandatory notification of trade 15 mar 2021 16:31

Vistin Pharma ASA: Mandatory notification of trade 15 mar 2021 16:26

Vistin Pharma ASA: Mandatory notification of trade